Keyword

Materials for Health

Sections

Articles

  • Research Fields
  • 2010-02-LF Interaction of proteins with nanostructured surfaces for biosensor development (UPMC, UCL)
  • 2010-03-LF Biological multi-functionalization and surface micropatterning of biomaterials (UB1, UCL)
  • 2010-04-LF Designing stimuli-responsive soft nanostructures for biomedical applications (UW,UB1)
  • 2010-09-LF Bio-inspired multiscale interfaces dental and skeletal reconstruction biomaterials (IST, UB1)
  • 2010-12-EM Responsive Biocatalytic Surfaces Based on Polymer Nanotubes – Structure, Dynamics, Applications (UCL, UPMC)
  • 2010-14-EM Magnetic hybrid materials for triggered drug delivery and optical properties of intraocular lenses (ULG, UB1)
  • 2011-01-LF : Surface patterning and bulk nanostructuring to develop new Magnesium alloys for biomedical applications (INPG-SIMAP, UW-WIN)
  • 2011-03-LF Preparation of drug-loaded scaffolds for biomedical applications using supercritical fluid technology (UB1-ISM, ULG-CERM)
  • 2011-04-EM Magnetic Micelles as Therapy and Diagnostic Agents (UW-Chemistry, UB1-LCPO)
  • 2011-17-LF Intraocular lenses with functionalized surfaces by biomolecules in relation with lens epithelial cell adhesion (ULG-MSLAB&LHC, UB1-CBMN)
    IOLs are functionalized with active principles (to modulate cell adhesion)...
  • 2012-01-EM Design and characterization of stimuli-responsive membranes with tunable surface properties for biomedical applications (UCL-IMCN,UPMC-LRS)
  • 2012-04-LF Polypeptide-based multifunctional nano-assemblies for biomedical imaging and drug delivery (UCL-IMCN, UB1-LCPO)
  • 2012-05-EM Magnesium-based biomaterials: From surface functionalization to cellular evaluation (IST-ICEMS, UPMC-LCMC)
  • 2012-06-LF Antibacterial Coatings for Households and Biomaterials made from Copolymer Materials Based on Poly(ionic liquid) (UB1-LCPO, ULG-CERM)
  • 2012-09-EM Design, synthesis and use of polypeptides as biosynthetic nanomachines (ULg-NANOCHEM, UB1-LCPO)
  • 2012-12-LF A microfluidic platform for synthesis of controlled release nanoparticles for targeted cancer therapy (UB1-LoF, UW-WIN)
    Nanoparticle drug carriers that combine targeted drug therapy with controlled release are (...)
  • Missions
  • EMMI newsletter Feb 2013